Literature DB >> 1633452

Dose prescription and dose-volume effects in radiosurgery.

J C Flickinger1, L D Lunsford, D Kondziolka.   

Abstract

The optimal use of radiosurgery as a treatment technique requires thorough planning, including careful fitting of the high-dose treatment volume to the target volume, and an understanding of the effects of high-dose single-fraction irradiation on both the target volume and the surrounding normal brain. The integrated logistic formula appears to be useful as an aid for predicting the risks of complications from radiosurgery, but greater understanding of the radiation tolerance for all the different areas of the brain (particularly the cranial nerves) is needed. The risk of developing MR imaging-defined changes after radiosurgery for AVMs was significantly related to predictions from the integrated logistic formula. The obliteration rate of AVMs after radiosurgery was volume dependent. Our assessment of the integrated logistic formula to date also indicates that it provides a reasonable guide for predicting complications in the radiosurgical treatment of meningiomas and in the treatment of solitary brain metastases using a combination of fractionated whole-brain irradiation and radiosurgery. The formula did not adequately predict complications in the treatment of AOVMs, however. In the treatment of acoustic tumors, the risks of injury to cranial nerves V, VII, and VIII clearly varied with treatment volume. Further data are needed to fully understand the therapeutic dose-response functions and volume effects for the obliteration of AVMs, the prevention of rebleeding from AOVMs, and growth arrest of meningiomas and acoustic neuromas.

Entities:  

Mesh:

Year:  1992        PMID: 1633452

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

1.  Radiosurgery with the first Austrian cobalt-60 Gamma-unit. A one year experience.

Authors:  G Pendl; O Schröttner; G M Friehs; J Legat; K Leber; M Mokry; G Papaefthymiou; G Langmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

2.  AVM resection after radiation therapy--clinico-morphological features and microsurgical results.

Authors:  Siamak Asgari; Hischam Bassiouni; Elke Gizewski; Johannes A P van de Nes; Dietmar Stolke; Ibrahim Erol Sandalcioglu
Journal:  Neurosurg Rev       Date:  2010-01       Impact factor: 3.042

3.  Radiosurgical management of pediatric arteriovenous malformations.

Authors:  Douglas Kondziolka; Hideyuki Kano; Huai-che Yang; John C Flickinger; L Lunsford
Journal:  Childs Nerv Syst       Date:  2010-07-06       Impact factor: 1.475

4.  Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery.

Authors:  Livia C Bianchi; Marcello Marchetti; Lorenzo Brait; Achille Bergantin; Ida Milanesi; Giovanni Broggi; Laura Fariselli
Journal:  Neurol Sci       Date:  2009-09-23       Impact factor: 3.307

Review 5.  Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife.

Authors:  Jay Jagannathan; Chun-Po Yen; Nader Pouratian; Edward R Laws; Jason P Sheehan
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

6.  Safety of multiple stereotactic radiosurgery treatments for multiple brain lesions.

Authors:  Virany H Hillard; Lynn L Shih; Shing Chin; Chitti R Moorthy; Deborah L Benzil
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130

7.  Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.

Authors:  Mehran Yusuf; Abbas Rattani; Jeremy Gaskins; Alexandria L Oliver; Steven F Mandish; Eric Burton; Michael E May; Brian Williams; Dale Ding; Mayur Sharma; Donald Miller; Shiao Woo
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

8.  Radiotherapy planning using MRI.

Authors:  Maria A Schmidt; Geoffrey S Payne
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.